$308.01
1.08% yesterday
NYSE, May 14, 10:14 pm CET
ISIN
US91324P1021
Symbol
UNH

UnitedHealth Target price 2025 - Analyst rating & recommendation

UnitedHealth Classifications & Recommendation:

Buy
79%
Hold
17%
Sell
3%

UnitedHealth Price Target

Target Price $450.68
Price $308.01
Potential 46.32%
Number of Estimates 22
22 Analysts have issued a price target UnitedHealth 2026 . The average UnitedHealth target price is $450.68. This is 46.32% higher than the current stock price. The highest price target is $594.00 92.85% , the lowest is $350.00 13.63% .
A rating was issued by 29 analysts: 23 Analysts recommend UnitedHealth to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the UnitedHealth stock has an average upside potential 2026 of 46.32% . Most analysts recommend the UnitedHealth stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029


Dec '24 2025
Estimates
Revenue Billion $ 400.28 450.43
8.83% 12.53%
Net Margin 3.53% 4.66%
40.27% 32.16%

21 Analysts have issued a sales forecast UnitedHealth 2025 . The average UnitedHealth sales estimate is $450b . This is 9.85% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $458b 11.76% , the lowest is $444b 8.24% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $400b 8.83%
2025 $450b 12.53%
2026 $481b 6.79%
2027 $513b 6.60%
2028 $552b 7.74%
2029 $613b 10.90%

15 UnitedHealth Analysts have issued a net profit forecast 2025. The average UnitedHealth net profit estimate is $21.0b . This is 3.50% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.6b 3.89% , the lowest is $18.8b 13.67% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $14.1b 35.00%
2025 $21.0b 48.83%
2026 $24.2b 15.27%
2027 $28.1b 16.11%
2028 $33.2b 17.98%
2029 $37.7b 13.75%

Net Margin

2024 3.53% 40.27%
2025 4.66% 32.16%
2026 5.03% 7.94%
2027 5.48% 8.95%
2028 6.00% 9.49%
2029 6.16% 2.67%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Dec '24 2025
Estimates
Earnings Per Share $ 15.51 23.08
35.00% 48.81%
P/E 13.34
EV/Sales 0.76

15 Analysts have issued a UnitedHealth forecast for earnings per share. The average UnitedHealth EPS is $23.08 . This is 3.51% lower than earnings per share in the financial year 2024. The highest EPS forecast is $24.85 3.89% , the lowest is $20.65 13.67% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $15.51 35.00%
2025 $23.08 48.81%
2026 $26.61 15.29%
2027 $30.89 16.08%
2028 $36.45 18.00%
2029 $41.46 13.74%

P/E ratio

Current 12.88 58.89%
2025 13.34 3.57%
2026 11.58 13.19%
2027 9.97 13.90%
2028 8.45 15.25%
2029 7.43 12.07%

Based on analysts' sales estimates for 2025, the UnitedHealth stock is valued at an EV/Sales of 0.76 and an P/S ratio of 0.62 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.83 40.29%
2025 0.76 9.04%
2026 0.71 6.36%
2027 0.66 6.20%
2028 0.62 7.18%
2029 0.56 9.83%

P/S ratio

Current 0.68 45.19%
2025 0.62 8.97%
2026 0.58 6.35%
2027 0.54 6.20%
2028 0.51 7.19%
2029 0.46 9.83%

Current UnitedHealth Upgrades & Downgrades

Analyst Rating Action Date
Oppenheimer
Outperform
Outperform
Unchanged May 14 2025
Keybanc
Overweight
Overweight
Unchanged May 14 2025
B of A Securities
Buy
Neutral
Downgrade May 14 2025
Baird
Outperform
Outperform
Unchanged May 14 2025
Wells Fargo
Overweight
Overweight
Unchanged May 14 2025
Deutsche Bank
Buy
Buy
Unchanged May 14 2025
Morgan Stanley
Overweight
Overweight
Unchanged May 14 2025
Analyst Rating Date
Unchanged
Oppenheimer:
Outperform
Outperform
May 14 2025
Unchanged
Keybanc:
Overweight
Overweight
May 14 2025
Downgrade
B of A Securities:
Buy
Neutral
May 14 2025
Unchanged
Baird:
Outperform
Outperform
May 14 2025
Unchanged
Wells Fargo:
Overweight
Overweight
May 14 2025
Unchanged
Deutsche Bank:
Buy
Buy
May 14 2025
Unchanged
Morgan Stanley:
Overweight
Overweight
May 14 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today